Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma

Journal of the American College of Surgeons

Volumn 198, Issue 3, 2004, Pages 410-421

  Wiesenauer, Chad A ^a   Yip Schneider, Michele T ^a   Wang, Yufang ^b   Schmidt, C Max ^a,b,c,d  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BLOTTING, WESTERN; BUTADIENES; CARCINOMA, HEPATOCELLULAR; CELL COUNT; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; LIVER NEOPLASMS; MAP KINASE KINASE KINASE 1; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NITRILES; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 1442335098     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2003.10.004     Document Type: Article

References (26)

1. Feo F., Pascale R.M., Simile M.M., et al. Genetic alterations in liver carcinogenesis implications for new preventive and therapeutic strategies. Crit Rev Oncog. 11:2000;19-62.
2. Van Biesen T., Hawes B.E., Luttrell D.K., et al. Receptor-tyrosine- kinase and GBγ mediated MAPK kinase activation by a common signaling pathway. Nature. 376:1996;781-784.
3. Lenormand P., Sardet C., Pages G., et al. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAPK kinase kinase (p45mapkk) in fibroblasts. J Cell Biol. 122:1993;1079-1088.
4. Lenormand P., Ages G., Sardet C., et al. MAP kinases activation, subcellular localization and role in the control of cell activation. Adv Second Messenger Phosphoprotein Res. 28:1993;237-244.
5. Davis R.J. The mitogen activated protein kinase signal transduction pathway. J Biol Chem. 268:1993;14553-14556.
6. Mansouer S.J., Mathen W.T., Harmann A.S., et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:1994;966-970.
7. Rodriguez G.A., Park M., Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J. 16:1997;2634-2645.
8. Boylan J.M., Gruppuso P.A. A comparative study of the hepatic mitogen-activated protein kinase and Jun-NH2-terminal kinase pathways in the late gestation fetal rat. Cell Growth Differ. 7:1996;1261-1269.
9. Bornfeldt KE, Campbell JS, Koyama H, et al. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J Clin Invest 100:875-885
10. Schmidt C.M. The role of Gi, Gs and Gq/11-protein linked MAPK signaling in the regulation of hepatocellular carcinoma growth. 1998;UMI Publishers, Washington, DC. (Dissertation).
11. Schmidt C.M., McKillop I.H., Cahill P.A., Sitzmann J.V. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Bioch Biophy Res Comm. 236:1997;54-58.
12. Ito Y., Sasaki Y., Horimoto M., et al. Activation of mitogen-activated protein kinase/extracellular signal-regulated protein kinase in human hepatocellular carcinoma. Hepatology. 27:1998;951-958.
13. Schmidt C.M., McKillop I.H., Cahill P.A., Sitzmann J.V. Altered Gq/G11 guanine nucleotide regulatory protein expression in a rat model of hepatocellular carcinoma role in mitogenesis. Hepatology. 29:1999;371-378.
14. McKillop I.H., Nilesh V., Schmidt C.M., et al. Enhanced Gi-protein mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma. Hepatology. 29:1999;412-420.
15. McKillop I.H., Schmidt C.M., Cahill P.A., Sitzmann J.V. Inhibitory guanine nucleotide regulatory protein activation of mitogen activated protein kinase in hepatocellular carcinoma. Eur J Gastro Hep. 11:1999;761-768.
16. Mitsui H., Takuwa N., Maruyama T., et al. The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int J Cancer. 92:2001;55-62.
17. Fukudo K., Tsuchihara K., Hijikata M., et al. Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli. Hepatology. 33:2001;159-165.
18. Hayashi J., Aoki H., Kajino K. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with the tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α Hepatology. 32:2000;958-961.
19. Alessi D.R., Cuenda A., Cohen P., et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 270:1995;27489-27494.
20. Favata M.F., Horiuchi K.Y., Manos E.J., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 273:1998;18623-18632.
21. Ito T., Shiraki K., Sugimoto K., et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 31:2000;1080-1085.
22. Ikeguchi M., Ueda T., Sakatani T., et al. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol. 11:2002;33-40.
23. Watanabe J., Kushihata F., Honda K., et al. Bcl-xL overexpression in human hepatocellular carcinoma. Int J Oncol. 21:2002;515-519.
24. Takehara T., Liu X., Fujimoto J., et al. Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology. 34:2001;55-61.
25. Carloni V., Mazzocca A., Pantaleo P., et al. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells. Hepatology. 34:2001;42-49.
26. Sebolt-Leopold J.S., Dudley D.T., Herrera R., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med. 5:1999;810-816.